Dhootpapeshwar Vasant Kusumakar Ras
SKU:
24814
Categories: Diabetes Care and Sugar Control, Kidney and Urinary Health Support
Brand: Shree Dhootapapeshwar
HSN Code: 30049011Pack Size: 1000 TAB
₹ 67,285.00 Original price was: ₹ 67,285.00.₹ 57,192.25Current price is: ₹ 57,192.25.
1 in stock
66
People watching this product now!
38
Items sold in last hour
Add ₹ 999.00 to cart and get free shipping!
Fast & Reliable Delivery
100% Genuine Product
Secure Payment Options
Dedicated Customer Support
Description
Vasant Kusumakar Rasa
Properties:
Rasayana (Rejuvenative) Yoga
Highly effective in Prameha Vyadhi (Diabetes & related complications)
Indications:
Madhumeha (Diabetes Mellitus)
Vatanadi Vikruti (Neurological disorders due to Vata imbalance)
Netrapatal Vikruti (Retinal disorders, Diabetic retinopathy)
Vrukka Vikruti (Kidney disorders, Diabetic nephropathy)
Padatal Vrana (Diabetic wounds, foot ulcers)
Napunsakata (Impotence, Sexual weakness)
Dosage & Anupan (Vehicle):
Dosage: 1 to 2 tablets, 1–2 times daily
Anupan:
Honey
Milk
As per the disease condition
Reviews (0)
Rated 0 out of 5
0 reviews
Rated 5 out of 5
0
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
Be the first to review “Dhootpapeshwar Vasant Kusumakar Ras” Cancel reply
Disclaimer:
Product details, including colors and availability, may vary slightly. Always read descriptions carefully before purchase....
Read More
Product details, including colors and availability, may vary slightly. Always read descriptions carefully before purchase. We do not encourage self-medication. Information provided on this site or linked sources is not a substitute for professional medical advice. Please consult a qualified healthcare provider before using any medication, supplement, or booster. A proper medical check-up is essential to determine the correct dosage, frequency, and duration based on individual needs. Returns are subject to our return policy.
Related products
100 TAB
10 TAB
60 TAB
10 TAB
30 CAP
10 TAB



Reviews
Clear filtersThere are no reviews yet.